Mr. Alex Blanchard reports

LEXARIA BIOSCIENCE ISSUES OPTIONS

Lexaria Bioscience Corp. has made an option award.

As a result of a new staffing position being filled, Lexaria is issuing 30,000 stock options with an exercise price of $1.16 (U.S.) that will vest as to 10,000 per year until April 15, 2021.

About Lexaria Bioscience Corp.

Lexaria Bioscience has developed and outlicenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules.

We seek Safe Harbor.